Royalty financing is a strategy that allows (typically) a small cap company to gain access to capital for launching a product in exchange for a percentage of sales generated after launch. Essentially, … [Read more...] about Topic of the Week | Royalty Financing
Topic of the week
Topic of the Week | Antibody Drug Conjugates
When it comes to the treatment of cancer, there are a variety of modalities oncologists have in their arsenal by which to treat patients. This depends upon the stage (or how progressed the disease is) … [Read more...] about Topic of the Week | Antibody Drug Conjugates
Topic of the Week | Enzyme Replacement Therapies
Enzyme replacement therapy (abbreviated ERT) is a rather large market that addresses many rare diseases. Oftentimes, patients with these diseases have a genetic defect whereby their body either does … [Read more...] about Topic of the Week | Enzyme Replacement Therapies
Gene Therapy Exciting, But Early
Gene therapy involves inserting genetic material into cells to prevent, cure, or correct a disease caused by genetic abnormalities whereas gene editing involves making actual changes to the genetic … [Read more...] about Gene Therapy Exciting, But Early
Partnerships & Licensing Deals
Partnership & Licensing Deals | Topic of The WeekA ubiquitous challenge for developmental-stage biopharma companies is raising capital to advance their assets through clinical trials with the hope … [Read more...] about Partnerships & Licensing Deals
Put strategies
Our research mainly focuses on long opportunities (make money from a stock’s value appreciating), but along the way we uncover short opportunities (make money from a stock’s value depreciating) in … [Read more...] about Put strategies
Top 5 Red Flags In Biotech
Biotech is an exciting, volatile and at times excessively confusing space. Unfortunately, this combination exposes investors to a large volume of companies all claiming to have innovative … [Read more...] about Top 5 Red Flags In Biotech
Topic of The Week | Form 4s
SEC filings can have an immense impact on stocks you hold. Unfortunately, they are often confusing and time-consuming to fully understand. In this week's topic of the week, we will discuss Form 4s, … [Read more...] about Topic of The Week | Form 4s
Topic of The Week | Risk Management
The broader markets have hit numerous all-time highs in 2021, fueled by robust corporate earnings beating analyst expectations by healthy margins, easing yields, an accommodative fed, and economic … [Read more...] about Topic of The Week | Risk Management
The Emergence of Covid-19 Variants
Topic of The Week: Covid-19 Variants We offer an equity analysis subscription service with; nightly email, SMS alerts, in-depth reports, and more. Try us out with a free trial and cancel anytime … [Read more...] about The Emergence of Covid-19 Variants
You must be logged in to post a comment.